Stock Scorer

Orthofix Medical Inc. (OFIX)

Orthofix Medical Inc. reported revenue of 210.9M USD for the quarter ending 30 June 2026, up 3.8% from 203.1M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 210.9M +3.8%
Gross Profit Q2 '26 · ending 30 June 2026 149.7M +7.3%
Operating Income Q2 '26 · ending 30 June 2026 -8.1M —
Net Income Q2 '26 · ending 30 June 2026 -15.8M —
Cost of Revenue Q2 '26 · ending 30 June 2026 61.2M -3.7%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -6.2M -153.5%
Free Cash Flow Q2 '26 · ending 30 June 2026 -18.9M -516.6%
Shares Outstanding Q2 '26 · ending 30 June 2026 40.9M +4.4%
EPS Q2 '26 · ending 30 June 2026 -1.53 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 822.3M-81.4M-92.2M-1.3M
20242024-12-31 799.5M-84.6M-126M-9.1M
20232023-12-31 746.6M-139.1M-151.4M-106M
20222022-12-31 460.7M-13.3M-19.7M-32.9M
20212021-12-31 464.5M-8.3M-38.4M690K
20202020-12-31 406.6M-6.3M2.5M58.8M
20192019-12-31 460M-18.8M-28.5M13M
20182018-12-31 453M30.1M13.8M36.3M
20172017-12-31 433.8M40.8M6.2M24.3M
20162016-12-31 409.8M21.1M3.1M42.6M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30210.9M
Q1 '262026-03-31196.7M
Q4 '252025-12-31219.9M
Q3 '252025-09-30205.6M
Q2 '252025-06-30203.1M
Q1 '252025-03-31193.6M
Q4 '242024-12-31215.7M
Q3 '242024-09-30196.6M
Q2 '242024-06-30198.6M
Q1 '242024-03-31188.6M
Q4 '232023-12-31200.4M
Q3 '232023-09-30184M
Q2 '232023-06-30187M
Q1 '232023-03-31175.2M
Q4 '222022-12-31122.2M
Q3 '222022-09-30114M
Q2 '222022-06-30118.1M
Q1 '222022-03-31106.4M
Q4 '212021-12-31125.1M
Q3 '212021-09-30112.4M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30149.7M
Q1 '262026-03-31139.5M
Q4 '252025-12-31156.3M
Q3 '252025-09-30148.5M
Q2 '252025-06-30139.5M
Q1 '252025-03-31121.6M
Q4 '242024-12-31148.8M
Q3 '242024-09-30135.1M
Q2 '242024-06-30134.7M
Q1 '242024-03-31127.2M
Q4 '232023-12-31136.6M
Q3 '232023-09-30119.8M
Q2 '232023-06-30119.6M
Q1 '232023-03-31110.3M
Q4 '222022-12-3189.2M
Q3 '222022-09-3083.4M
Q2 '222022-06-3086.5M
Q1 '222022-03-3178.1M
Q4 '212021-12-3191.8M
Q3 '212021-09-3084.1M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-8.1M
Q1 '262026-03-31-14.4M
Q4 '252025-12-31494K
Q3 '252025-09-30-17M
Q2 '252025-06-30-16M
Q1 '252025-03-31-48.9M
Q4 '242024-12-31-11.5M
Q3 '242024-09-30-18.9M
Q2 '242024-06-30-24.9M
Q1 '242024-03-31-29.3M
Q4 '232023-12-31-18.3M
Q3 '232023-09-30-24.4M
Q2 '232023-06-30-36.6M
Q1 '232023-03-31-59.7M
Q4 '222022-12-31-11M
Q3 '222022-09-30-5.8M
Q2 '222022-06-306.6M
Q1 '222022-03-31-3.1M
Q4 '212021-12-31-9.4M
Q3 '212021-09-30-313K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-15.8M
Q1 '262026-03-31-20.9M
Q4 '252025-12-31-2.2M
Q3 '252025-09-30-22.8M
Q2 '252025-06-30-14.1M
Q1 '252025-03-31-53.1M
Q4 '242024-12-31-29.1M
Q3 '242024-09-30-27.4M
Q2 '242024-06-30-33.4M
Q1 '242024-03-31-36M
Q4 '232023-12-31-22.2M
Q3 '232023-09-30-28.9M
Q2 '232023-06-30-39.4M
Q1 '232023-03-31-60.9M
Q4 '222022-12-31-7.1M
Q3 '222022-09-30-10.7M
Q2 '222022-06-302.5M
Q1 '222022-03-31-4.5M
Q4 '212021-12-31-32.8M
Q3 '212021-09-30-2.2M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-3061.2M
Q1 '262026-03-3157.2M
Q4 '252025-12-3163.6M
Q3 '252025-09-3057.1M
Q2 '252025-06-3063.6M
Q1 '252025-03-3172M
Q4 '242024-12-3166.8M
Q3 '242024-09-3061.6M
Q2 '242024-06-3063.9M
Q1 '242024-03-3161.4M
Q4 '232023-12-3163.8M
Q3 '232023-09-3064.2M
Q2 '232023-06-3067.5M
Q1 '232023-03-3164.9M
Q4 '222022-12-3133.1M
Q3 '222022-09-3030.6M
Q2 '222022-06-3031.6M
Q1 '222022-03-3128.3M
Q4 '212021-12-3133.3M
Q3 '212021-09-3028.3M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-6.2M
Q1 '262026-03-31-17.6M
Q4 '252025-12-3127.7M
Q3 '252025-09-3012.4M
Q2 '252025-06-3011.6M
Q1 '252025-03-31-18.4M
Q4 '242024-12-3123.7M
Q3 '242024-09-3011.7M
Q2 '242024-06-309M
Q1 '242024-03-31-18.6M
Q4 '232023-12-31-6.7M
Q3 '232023-09-30477K
Q2 '232023-06-30-5.5M
Q1 '232023-03-31-34M
Q4 '222022-12-312.3M
Q3 '222022-09-30-1.3M
Q2 '222022-06-30-4.9M
Q1 '222022-03-31-7.7M
Q4 '212021-12-3111.8M
Q3 '212021-09-306.4M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-18.9M
Q1 '262026-03-31-28.3M
Q4 '252025-12-3116.8M
Q3 '252025-09-302.5M
Q2 '252025-06-304.5M
Q1 '252025-03-31-25.1M
Q4 '242024-12-3115.2M
Q3 '242024-09-306.3M
Q2 '242024-06-30-360K
Q1 '242024-03-31-29.1M
Q4 '232023-12-31-21.3M
Q3 '232023-09-30-21.4M
Q2 '232023-06-30-17.9M
Q1 '232023-03-31-45.5M
Q4 '222022-12-31-2.9M
Q3 '222022-09-30-6.4M
Q2 '222022-06-30-10.6M
Q1 '222022-03-31-13M
Q4 '212021-12-315.6M
Q3 '212021-09-303.9M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3040.9M
Q1 '262026-03-3140.5M
Q3 '252025-09-3039.8M
Q2 '252025-06-3039.5M
Q1 '252025-03-3139.2M
Q3 '242024-09-3038.5M
Q2 '242024-06-3038M
Q1 '242024-03-3137.7M
Q3 '232023-09-3037.2M
Q2 '232023-06-3036.8K
Q1 '232023-03-3135.7K
Q3 '222022-09-3020.1K
Q2 '222022-06-3020.1K
Q1 '222022-03-3119.9K
Q3 '212021-09-3019.8K
Q2 '212021-06-3019.9K
Q1 '212021-03-3119.5M
Q3 '202020-09-3019.4M
Q2 '202020-06-3019.2M
Q1 '202020-03-3119.3M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-1.53
Q1 '262026-03-31-1.50
Q4 '252025-12-31-2.33
Q3 '252025-09-30-3.03
Q2 '252025-06-30-3.17
Q1 '252025-03-31-3.69
Q4 '242024-12-31-3.29
Q3 '242024-09-30-3.13
Q2 '242024-06-30-3.19
Q1 '212021-03-31-1.49
Q4 '202020-12-310.13
Q3 '202020-09-301.20
Q2 '202020-06-30-1.18
Q1 '202020-03-31-0.25
Q4 '192019-12-31-1.52
Q3 '192019-09-30-1.66
Q2 '192019-06-300.41
Q1 '192019-03-310.49
Q4 '182018-12-310.71
Q3 '182018-09-300.33